Description

Trimetazidin (trimetazidine) Coated Tablets 20 mg. №60

Ingredients

Active ingredient: Trimetazidine 20 mg per tablet.

Dosage

Recommended dosage: The usual dose is 20 mg three times a day. Consult a healthcare professional for personalized recommendations.

Indications

Indicated for: Symptomatic treatment of angina pectoris.

Contraindications

Do not use if: Allergic to trimetazidine or any other ingredients in the product. Consult a doctor before use.

Directions

– Take one tablet three times a day with meals.
– Swallow the tablet whole with a glass of water.

Scientific Evidence

Trimetazidine is an anti-ischemic metabolic agent that has shown efficacy in the treatment of angina pectoris. It works by improving myocardial glucose utilization and maintaining cellular functions under ischemic conditions. Clinical studies have demonstrated the benefits of trimetazidine in reducing angina symptoms, improving exercise tolerance, and enhancing quality of life in patients with stable angina.

Additional Information

Trimetazidine has a favorable safety profile with minimal side effects. However, it is essential to follow the prescribed dosage and consult a healthcare provider before starting the medication. Regular monitoring may be necessary to assess the treatment’s effectiveness and adjust the dosage if needed.

Pharmacological Effects: Trimetazidine acts by shifting myocardial metabolism from fatty acid oxidation to glucose oxidation, thereby preserving energy production during ischemic episodes. This mechanism helps improve cardiac function and reduce ischemic damage.

Clinical Trials: Clinical trials have shown that trimetazidine effectively reduces the frequency and severity of angina attacks, leading to improved exercise capacity and overall quality of life in patients with stable angina. Studies have also highlighted its role in preventing myocardial damage during ischemic events.